CRF Connect Logo

Heart Failure

Clinical Indications and Science Learning Series

Guidelines, Decision Making & Controversies

Advertisement

Heart Failure >
Guidelines, Decision Making & Controversies

Episodes

How Helpful Can EFIC Be in the US?
How Helpful Can EFIC Be in the US?
29 min.
Use of AI for Improved HF Event Detection and Automated Drug Titration in Patients With and RPM Deice Planning for the Future: Perspective 1
Use of AI for Improved HF Event Detection and Automated Drug Titration in Patients With and RPM Deice Planning for the Future: Perspective 1
7 min.
Use of AI for Improved HF Event Detection and Automated Drug Titration in Patients With and RPM Deice Planning for the Future: Perspective 2
Use of AI for Improved HF Event Detection and Automated Drug Titration in Patients With and RPM Deice Planning for the Future: Perspective 2
7 min.
Regulatory Considerations for the Use of AI for Treating Patients With Heart Failure: The Intersection of Drugs and Devices
Regulatory Considerations for the Use of AI for Treating Patients With Heart Failure: The Intersection of Drugs and Devices
11 min.
This Strategy Has Saved the Startup Medical Device Sector
This Strategy Has Saved the Startup Medical Device Sector
7 min.
Down-Stream Challenges: Reimbursement and Guidelines
Down-Stream Challenges: Reimbursement and Guidelines
8 min.
Kansas City Cardiomyopathy Questionnaire:  Why All the Fuss?
Kansas City Cardiomyopathy Questionnaire: Why All the Fuss?
4 min.
Evidence That Challenges the Validity of KCCQ as a Measure of Quality of Life in Both Blinded and Unblinded Studies
Evidence That Challenges the Validity of KCCQ as a Measure of Quality of Life in Both Blinded and Unblinded Studies
10 min.
Evidence Supporting the Use of KCCQ as a Valid Measure of Quality of Life in Both Blinded and Unblinded Studies
Evidence Supporting the Use of KCCQ as a Valid Measure of Quality of Life in Both Blinded and Unblinded Studies
12 min.
Which ADHF Patients Need Devices?: A Clinician's Perspective
Which ADHF Patients Need Devices?: A Clinician's Perspective
9 min.
Current Challenges Related to Device-Based Therapies for ADHF: Perspectives of an Investigator
Current Challenges Related to Device-Based Therapies for ADHF: Perspectives of an Investigator
7 min.
Current Challenges Related to Device-Based Therapies for ADHF: Perspectives from Industry
Current Challenges Related to Device-Based Therapies for ADHF: Perspectives from Industry
8 min.
What Are the Major Challenges?
What Are the Major Challenges?
9 min.
Clinical Trial Options
Clinical Trial Options
8 min.
Inflammation and HFpEF: Rationale for HERMES
Inflammation and HFpEF: Rationale for HERMES
9 min.
Inflammation as a Target in Acute HF
Inflammation as a Target in Acute HF
10 min.
Is There a Role for Obesity in the Progression of Heart Failure With a Reduced Ejection Fraction?
Is There a Role for Obesity in the Progression of Heart Failure With a Reduced Ejection Fraction?
10 min.
Weight Loss Improves Outcome in HFpEF:  Summarizing the Clinical Evidence
Weight Loss Improves Outcome in HFpEF: Summarizing the Clinical Evidence
9 min.
How Does Weight Loss Improve Hemodynamics in Patients With HFpEF
How Does Weight Loss Improve Hemodynamics in Patients With HFpEF
10 min.
From Obesity to Inflammation: Common Pathways and New Opportunities in HF
From Obesity to Inflammation: Common Pathways and New Opportunities in HF
10 min.
Resurgence of Interest in the Role of Inflammaion in HF
Resurgence of Interest in the Role of Inflammaion in HF
10 min.
Obesity:  Assessing the Weight of the Evidence
Obesity: Assessing the Weight of the Evidence
9 min.
MRAs Redux: New Evidence in Heart Failure
MRAs Redux: New Evidence in Heart Failure
12 min.
Special Late-Breaking Clinical Science Abstract: Electrophysiological Characteristics and Clinical Outcomes of Truncal, Fascicular and Left Ventricular Septal Pacing in Patients Receiving Left Bundle Branch Area Pacing
Special Late-Breaking Clinical Science Abstract: Electrophysiological Characteristics and Clinical Outcomes of Truncal, Fascicular and Left Ventricular Septal Pacing in Patients Receiving Left Bundle Branch Area Pacing
11 min.
Is There a Difference in the Benefits of AF Ablation in HFrEF vs HFpEF?
Is There a Difference in the Benefits of AF Ablation in HFrEF vs HFpEF?
13 min.
Left Bundle Branch Area Pacing:  Implications for Long Term LV Function in Heart Failure
Left Bundle Branch Area Pacing: Implications for Long Term LV Function in Heart Failure
12 min.
Advances in Defibrillation for Patients With Heart Failure: Extravascular ICD and Beyond
Advances in Defibrillation for Patients With Heart Failure: Extravascular ICD and Beyond
13 min.
Left Atrial Appendage Closure: Should We Give Heart Failure Patients With AF the OPTION
Left Atrial Appendage Closure: Should We Give Heart Failure Patients With AF the OPTION
14 min.
Shaping the Future of Heart Failure
Shaping the Future of Heart Failure
10 min.
Mineralocorticoid Antagonism in Heart Failure: Mechanistic Foundations
Mineralocorticoid Antagonism in Heart Failure: Mechanistic Foundations
10 min.
Too Good to Be True? Five Top Lessons of Major GLP-1 Agonists Trials
Too Good to Be True? Five Top Lessons of Major GLP-1 Agonists Trials
18 min.
Growing Role of AI in HF Diagnostics: Are There Any Pitfalls
Growing Role of AI in HF Diagnostics: Are There Any Pitfalls
10 min.
Patient Reported Outcomes in National Registries: Why and How?
Patient Reported Outcomes in National Registries: Why and How?
22 min.
Case Resolution: TTVI in the Failing Right Heart
Case Resolution: TTVI in the Failing Right Heart
9 min.
TTVI in in the Failing Right Heart
TTVI in in the Failing Right Heart
16 min.
Case Presentation: TTVI in the Failing Right Heart
Case Presentation: TTVI in the Failing Right Heart
3 min.
Requirements for GDMT in UPSTREAM AVR Clinical Trials in (1) Preserved EF or (2) Reduced EF Patients
Requirements for GDMT in UPSTREAM AVR Clinical Trials in (1) Preserved EF or (2) Reduced EF Patients
18 min.
The Concepts of Biological and Physical Reverse Remodeling
The Concepts of Biological and Physical Reverse Remodeling
15 min.